Vigers Michael P, Lobo Samuel, Najafi Saeed, Dubose Austin, Tsay Karen, Ganguly Pritam, Longhini Andrew P, Jin Yingying, Buratto Steven K, Kosik Kenneth S, Shell M Scott, Shea Joan-Emma, Han Songi
Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA 93106.
Department of Chemical Engineering, University of California, Santa Barbara, CA 93106.
Proc Natl Acad Sci U S A. 2025 May 6;122(18):e2421391122. doi: 10.1073/pnas.2421391122. Epub 2025 Apr 28.
Tau forms fibrillar aggregates that are pathological hallmarks of a family of neurodegenerative diseases known as tauopathies. The synthetic replication of disease-specific fibril structures is a critical gap for developing diagnostic and therapeutic tools. This study debuts a strategy of identifying a critical and minimal folding motif in fibrils characteristic of tauopathies and generating seeding-competent fibrils from the isolated tau peptides. The 19-residue jR2R3 peptide (295 to 313) which spans the R2/R3 splice junction of tau, and includes the P301L mutation, is one such peptide that forms prion-competent fibrils. This tau fragment contains the hydrophobic VQIVYK hexapeptide that is part of the core of all known pathological tau fibril structures and an intramolecular counterstrand that stabilizes the strand-loop-strand (SLS) motif observed in 4R tauopathy fibrils. This study shows that P301L exhibits a duality of effects: it lowers the barrier for the peptide to adopt aggregation-prone conformations and enhances the local structuring of water around the mutation site to facilitate site-directed pinning and dewetting around sites 300-301 to achieve in-register stacking of tau to cross β-sheets. We solved a 3 Å cryo-EM structure of jR2R3-P301L fibrils in which each protofilament layer contains two jR2R3-P301L copies, of which one adopts a SLS fold found in 4R tauopathies and the other wraps around the SLS fold to stabilize it, reminiscent of the three- and fourfold structures observed in 4R tauopathies. These jR2R3-P301L fibrils are competent to template full-length 4R tau in a prion-like manner.
tau蛋白形成纤维状聚集体,是一类被称为tau蛋白病的神经退行性疾病的病理标志。疾病特异性纤维结构的合成复制是开发诊断和治疗工具的关键差距。本研究首次提出了一种策略,即在tau蛋白病特征性纤维中识别关键且最小的折叠基序,并从分离的tau肽生成具有种子活性的纤维。19个氨基酸的jR2R3肽(295至313)跨越tau蛋白的R2/R3剪接位点,并包含P301L突变,就是这样一种能形成具有朊病毒活性纤维的肽。这个tau片段包含疏水性六肽VQIVYK,它是所有已知病理性tau纤维结构核心的一部分,以及一条分子内反向链,可稳定在4R tau蛋白病纤维中观察到的链-环-链(SLS)基序。本研究表明,P301L表现出双重作用:它降低了肽采用易于聚集构象的障碍,并增强了突变位点周围水的局部结构化,以促进300-301位点周围的位点定向固定和去湿,从而实现tau蛋白的对齐堆积以形成交叉β-折叠。我们解析了jR2R3-P301L纤维的3 Å冷冻电镜结构,其中每个原纤维层包含两个jR2R3-P301L拷贝,其中一个采用在4R tau蛋白病中发现的SLS折叠,另一个围绕SLS折叠缠绕以使其稳定,这让人联想到在4R tau蛋白病中观察到的三重和四重结构。这些jR2R3-P301L纤维能够以朊病毒样方式为全长4R tau蛋白提供模板。